| scholarly article | Q13442814 |
| P2093 | author name string | Jason N Dungu | |
| P2860 | cites work | Update on treatment of light chain amyloidosis | Q26829735 |
| Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis | Q28217930 | ||
| Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial | Q28304712 | ||
| Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease | Q28546193 | ||
| Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens | Q33508070 | ||
| Antibodies to human serum amyloid P component eliminate visceral amyloid deposits | Q34144814 | ||
| Primary systemic amyloidosis: clinical and laboratory features in 474 cases. | Q34320169 | ||
| Senile systemic amyloidosis: clinical features at presentation and outcome | Q34340740 | ||
| Novel drugs targeting transthyretin amyloidosis | Q34400138 | ||
| Could late enhancement and need for permanent pacemaker implantation in patients undergoing TAVR be explained by undiagnosed transthyretin cardiac amyloidosis? | Q53637234 | ||
| Isolation and characterization of amyloid fibrils from tissue. | Q53706819 | ||
| Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis. | Q53772437 | ||
| Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis | Q55670644 | ||
| Tabulation of human transthyretin (TTR) variants, 2003 | Q58011075 | ||
| CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis | Q58853065 | ||
| Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival | Q58853078 | ||
| Correlation of histomorphological pattern of cardiac amyloid deposition with amyloid type: a histological and proteomic analysis of 108 cases | Q60976358 | ||
| Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis | Q61657843 | ||
| Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis | Q62083154 | ||
| Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation | Q64361284 | ||
| Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis | Q70023104 | ||
| The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement | Q74524530 | ||
| Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy | Q80833658 | ||
| Predictors of survival in patients with systemic light-chain amyloidosis and cardiac involvement initially ineligible for stem cell transplantation and treated with oral melphalan and dexamethasone | Q81762674 | ||
| Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction | Q85674220 | ||
| Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation | Q85856496 | ||
| Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans | Q34415207 | ||
| Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component | Q34485172 | ||
| Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction | Q34487487 | ||
| Prevalence of monoclonal gammopathy of undetermined significance | Q34506801 | ||
| Therapeutic strategies for human amyloid diseases | Q34743288 | ||
| T1 mapping and survival in systemic light-chain amyloidosis | Q34994098 | ||
| The amyloidogenic V122I transthyretin variant in elderly black Americans | Q35242225 | ||
| Light Chain Amyloid Fibrils Cause Metabolic Dysfunction in Human Cardiomyocytes | Q35783283 | ||
| Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis | Q35886289 | ||
| A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis | Q36159473 | ||
| Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis | Q36165179 | ||
| Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis | Q36384508 | ||
| Evaluation and management of the cardiac amyloidosis. | Q37013270 | ||
| Diflunisal for ATTR cardiac amyloidosis | Q37055082 | ||
| Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy | Q37301237 | ||
| Amyloid diseases of the heart: assessment, diagnosis, and referral | Q37819545 | ||
| The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug | Q37975816 | ||
| Cardiac transthyretin amyloidosis. | Q38034215 | ||
| Outcomes after heart transplantation for amyloid cardiomyopathy in the modern era. | Q38343098 | ||
| Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study | Q38425844 | ||
| Native T1 mapping in transthyretin amyloidosis | Q38442488 | ||
| Cardiovascular magnetic resonance in cardiac amyloidosis | Q38515487 | ||
| Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology | Q38532386 | ||
| Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy | Q40378952 | ||
| Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy | Q40388294 | ||
| Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African-Americans | Q40784560 | ||
| Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study | Q42646462 | ||
| A new era in the treatment of amyloidosis? | Q43961058 | ||
| Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). | Q44545593 | ||
| The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients | Q46169582 | ||
| V122I transthyretin variant in elderly black Americans | Q46206011 | ||
| Revised transthyretin Ile 122 allele frequency in African-Americans | Q46220573 | ||
| Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study | Q46645719 | ||
| Safety and efficacy of RNAi therapy for transthyretin amyloidosis | Q46836193 | ||
| Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis | Q47861129 | ||
| Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses | Q48033249 | ||
| Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. | Q48771344 | ||
| Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant | Q48847335 | ||
| Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men. | Q48867075 | ||
| Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. | Q50622497 | ||
| Prognostic significance of strain Doppler imaging in light-chain amyloidosis. | Q53066780 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 113-117 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | European cardiology | Q27727460 |
| P1476 | title | Cardiac Amyloid - An Update | |
| P478 | volume | 10 |
Search more.